Last reviewed · How we verify
NCT07097688: Regeneration
Regenerative Endodontic Treatment Using Sodium Hexametaphosphate (SHMP) For Necrotic Immature Permanent Anterior Teeth
Phase 1, PHASE2 trial testing Sodium Hexametaphosphate (SHMP) Inorganic polyphosphates (poly[P]) are linear polymers of orthophosphate (Pi) residues linked by energy-rich phosphoranhydride bonds, Ithas multiple physiological funct in Regenerative Inflammation in 60 participants. Participants enrolled and being followed up; not accepting new ones.
1 December 2025
Quick facts
| Lead sponsor | Ahmad Elheeny |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 29 June 2025 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 April 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Sodium Hexametaphosphate (SHMP) Inorganic polyphosphates (poly[P]) are linear polymers of orthophosphate (Pi) residues linked by energy-rich phosphoranhydride bonds, Ithas multiple physiological funct
Conditions studied
- Regenerative Inflammation — all drugs for Regenerative Inflammation →
Sponsor
Ahmad Elheeny
Who can join
Adults 7 to 11, any sex, with Regenerative Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
evaluate clinically and radiographically regenerative potential of sodium hexametaphosphate (SHMP) on stem cells from the apical papilla for 18-month randomized controlled trial
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07097688
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Regenerative Inflammation
Currently open trials in the same condition.
- NCT06338241 — Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model · Phase 4 · recruiting
Other Ahmad Elheeny trials
Trials by the same sponsor.
- NCT05878158 — Simvastatin Versus MTA in Pulpotomy of Immature Permanent Molars · EARLY_PHASE1 · unknown
- NCT05522270 — Concentrated Growth Factor Versus Platelet Rich Fibrin in Revitalization of Necrotic Young Permanent Incisors · NA · unknown
- NCT04279041 — In-vitro and In-vivo Comparative Evaluation of Rotary Fanta and Zunba Files in Root Canal Preparation of Infected Primar · NA · completed
- NCT04137861 — Evaluation of Furcal Perforation Repair in Primary Molars With MTA Versus Bioceramics (A Randomized Clinical Trial) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07097688 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ahmad Elheeny
- Last refreshed: 31 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07097688.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing